37
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Semi-Quinone Formation from the Catechol and Ortho-Quinone Metabolites of the Antitumor Agent VP-16–213

, , , , , & show all
Pages 371-384 | Published online: 07 Jul 2009
 

Abstract

The catechol metabolite of the antitumor agent VP-16–213 and the ortho-quinone of VP-16–213 - a secondary metabolite formed from the catechol … easily undergo auto-oxidation into a free radical at pH ≤ 7.4. By elevation of the pH from 7.4 to 10, an increase in the production of the free radical was observed, which was accompanied by the formation of products with higher hydrophylicity than the catechol and ortho-quinone, as found by HPLC-analysis. The hypefine structure of the free radical indicates that it is the semi-quinone radical of VP-16–213. At pH 12.5 a secondary radical is formed from the catechol and the ortho-quinone of VP-16–213 besides the semi-quinone radical. One-electron oxidation of the catechol with horseradish peroxidase/hydrogen peroxide resulted in the formation of the same radical as observed under alkaline conditions and subsequent oxidation to the ortho-quinone. If the ortho-quinone was incubated with NADPH cytochrome P-450 reductase, a free radical was detected by spin-trapping with POBN, but not without spin-trapping.

Studies on inactivation of πX174 DNA by the system ortho-quinone of VP-16–213/NADPH cytochrome P-450 reductase suggest that the semi-quinone radical may play a role in the process of inactivation of DNA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.